APA aipamena

Carlone, G., Simeone, R., Baraldo, M., Maestro, A., Zanon, D., Barbi, E., & Maximova, N. (2021). Area-under-the-Curve-Based Mycophenolate Mofetil Dosage May Contribute to Decrease the Incidence of Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients. J Clin Med.

Chicago Style aipamena

Carlone, Giorgia, Roberto Simeone, Massimo Baraldo, Alessandra Maestro, Davide Zanon, Egidio Barbi, and Natalia Maximova. "Area-under-the-Curve-Based Mycophenolate Mofetil Dosage May Contribute to Decrease the Incidence of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients." J Clin Med 2021.

MLA aipamena

Carlone, Giorgia, et al. "Area-under-the-Curve-Based Mycophenolate Mofetil Dosage May Contribute to Decrease the Incidence of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients." J Clin Med 2021.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.